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A Girl with del(4)(q33) and Occipital Encephalocele: 
Clinical Description and Molecular Genetic 
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ABSTRACT
We present clinical and developmental data on a girl with a de novo terminal deletion of the long arm of chro-
mosome 4, del(4)(q33). The patient was evaluated at birth and followed up until 5 years of age. She showed
facial and digital dysmorphism, a complex congenital heart defect, a large occipital encephalocele, and post-
natal growth deficiency. Her neuropsychomotor milestones were delayed, and she developed learning diffi-
culties. Apart from standard Giemsa banding, a molecular genetic analysis was performed using a compara-
tive genomic hybridization (CGH) array. This revealed a terminal deletion at the band 4q32.3, which is directly
adjacent to 4q33. The clinical findings in our patient differ from those described previously in patients with
del(4)(q33) and del(4)(q32), respectively. In particular, the prominent occipital encephalocele has not been ob-
served before in a terminal 4q deletion.
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INTRODUCTION
CHROMOSOME 4Q DELETIONS are rare, with an estimated in-cidence of 1/100,000 (Strehle and Bantock 2003). Dele-
tions of the terminal region of the long arm of chromosome 4
have been characterized as a distinct syndrome based on a num-
ber of common clinical features shared by previously reported
cases (Townes et al. 1979; Strehle et al. 2001). Common char-
acteristics are mild facial and digital stigmata (especially of the
fifth finger), cardiac, skeletal, gastrointestinal, and renal anom-
alies, developmental delay, learning difficulties, growth failure,
and a significant mortality (Mitchell et al. 1981; Yu et al. 1981;
Lin et al. 1988; Strehle and Bantock 2003).
Patients with large terminal deletions (4q31) are more se-
verely affected with the characteristic facial, skeletal, and de-
velopmental anomalies (Giuffrè et al. 2004). The region
4q31q34 may be critical for most of the clinical phenotype (Lin
et al. 1988). Some authors propose that the critical region for
the 4q terminal deletion syndrome is 4q33, and that genes in-
volved in facial, limb, cardiac, and central nervous system de-
velopment must reside on 4q33 (Keeling et al. 2001). Most
deletions occurred de novo and therefore carried a low recur-
rence risk (Strehle et al. 2001).
The deletion 4q33 has been described in 15 patients; most
of these cases presented with developmental delay and learn-
ing difficulties, facial and digital dysmorphisms, and congeni-
tal heart disease (Strehle and Bantock 2003). There are only 4
published cases of del(4)(q32), which will be discussed below
(Lin et al. 1988).
Here, we describe a patient evaluated repeatedly until the age
of 5 years with a terminal deletion of chromosome 4,
del(4)(q33), who in addition to the clinical features previously
reported in patients with terminal 4q33 deletion, showed a
prominent occipital encephalocele.
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MATERIALS AND METHODS
Patient
The patient was born at a gestational age of 38 weeks by
caesarian section as the first offspring of healthy, nonconsan-
guineous parents. Her mother and father were 23 years old at
the time of her birth. Vaginal bleeding was reported in the sec-
ond trimester of pregnancy. Birth weight was 2.9 kg (, 50th
centile) and her head circumference was 34 cm (. 50th cen-
tile). The newborn had Apgar scores of 8 at 1 min and 9 at 
5 min. She was noted to have dysmorphic craniofacial features,
including hypoplastic supraorbital ridges, large fontanelles, up-
wards slanting, short palpebral fissures, hypertelorism, glabel-
lar haemangioma, over-folded ear helix, microstomia, and
micrognathia (Fig. 1A). An occipital encephalocele was also
present, which was surgically removed at the second day of
life (Fig. 2). Magnetic resonance imaging of the brain per-
formed at 3 months showed an Arnold–Chiari malformation
type II, neuronal migration defects, and a supratentorial hy-
drocephalus. The patient was also noted to have hand and foot
deformities: overlapping fingers and clinodactyly of the 5th
digits, bilateral isodactyly of the toes, an overlap of the hy-
poplastic 5th toe over the 4th toe, and proximal implantation of
the 2nd toes (Fig. 1C). Additional findings included abnormal
labia minora, a prominent clitoris, and a sacrolumbar heman-
gioma. Chest X ray, echocardiogram, and cardiac catheteriza-
tion revealed a complex cardiac defect with cardiomegaly, pre-
ductal coarctation of the aorta, patent ductus arteriosus, and a
perimembranous ventricular septal defect. Corrective heart sur-
gery was performed on day 5 of life. The girl developed sec-
ondary pulmonary hypertension, which was controlled with
medication.
On follow up she showed postnatal onset growth deficiency
and feeding difficulties until 4 months of age. She displayed
good head control at 5 months and sat alone at 1 year. At that
time she had evidence of growth retardation with a weight of
5.9 kg (, 3rd centile) and a length of 70 cm (, 10th centile).
The clinical features remained unchanged (Fig. 1B,C).
She was re-evaluated at aged 4 years (Fig. 3); weight was
14.2 kg (10th centile), length was 92 cm (, 3rd centile), and
head circumference was 47 cm (, 3rd centile). Her neurode-
velopmental milestones were significantly delayed. Unaided
walking was possible from the age of 2.5 years. She was eat-
ing using her fingers and a spoon, but had problems with toi-
let training. She could say single words and carry out simple
orders. Vision and hearing were normal. She did not attend nurs-
ery, but enjoyed playing by herself or with other children.
Cytogenetic and molecular analyses
Chromosome analysis was performed on peripheral blood
lymphocytes from the patient and her parents. GTG-banding
was performed using standard protocols. A total of 20 GTG-
banded metaphases were examined with the complete analysis
of four karyotypes. For molecular analysis, the Agilent Human
Genome CGH microarray kit 44B (Agilent Technologies, Inc.)
was used. The microarray contains approximately 43,000 60-
mer oligonucleotide probes, which provide genome-wide cov-
erage for .30,000 mapped genes with a spatial resolution of
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FIG. 1. Facial features of the patient in the neonatal period (A) and at 1 year of life (B). Note the dysmorphic craniofacial fea-
tures described in the text. C: Details of her feet at birth and at 1 year of life, respectively.
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FIG. 2. Computerized tomogram of the patient’s head show-
ing a prominent occipital encephalocele.
FIG. 3. A: Full-body view of patient at the age of 4 years. B: Facial feature show persistence of the supraciliar and interciliar
frontal hemangioma. C: A close-up view of her feet.
30–35 kb (calculated using the nonrepeated sequences of the
genome). The experiment was performed as recommended by
the manufacturer. Briefly, patient genomic DNA was extracted
from peripheral blood using the Pure Gene kit (Gentra Systems,
Minneapolis, MN). Both reference DNA (Promega, Madison,
WI) and test DNA were digested with RsaI and AluI (Invitro-
gen, Carlsbad, CA), and then purified using a Clean and Con-
centrator™ kit (Zymo Research, Orange, CA). Purified test and
reference DNA samples were labeled with Cy5- and Cy3-la-
beled dCTPs (GE Healthcare Bio-Sciences Corp. Piscataway,
NJ), respectively, using a BioPrime random labeling kit (Invit-
rogen, Carlsbad, CA). The labeled test and reference DNA sam-
ples were combined and hybridized to the microarray slide. Af-
ter hybridization and washing, the slide was scanned on an
Agilent Microarray Scanner and captured images were analyzed
with Feature Extraction Software v8.1 and CGH Analytics 3.1
(Agilent Technologies, Inc.).
RESULTS
Figure 4 shows a G-banded metaphase from peripheral blood
lymphocytes. The normal and deleted chromosomes 4 are
shown with their corresponding ideogram. A de novo terminal
deletion with breakpoints at 4q33 was found. Parental chro-
mosomes were normal, indicating that the deletion had arisen
de novo and carried a low recurrence risk. Molecular analysis
using an array CGH kit revealed a terminal 25.7-MB deletion
at the breakpoint 4q32.3 (Fig. 5). The bands 4q33 and 4q32.3
could not be differentiated from each other by light microscopy
alone.
DISCUSSION
So far more than 100 patients have been reported with ter-
minal or interstitial deletions of chromosome 4q. According to
Strehle and Bantock, the 4q deletion syndrome falls under the
category of multiple congenital anomalies and mental retarda-
tion syndromes and has growth failure as a leading phenotypi-
cal characteristic (Strehle and Bantock 2003). The phenotype
and the severity of clinical manifestations are variable and de-
pend on the exact site and extension of the deleted 4q segment
(Giuffrè et al. 2004). Comparison of the clinical signs in our
patient with those published by other research groups showed
that our patient has the key features present in the 15 patients
described with 4q33 deletion (Strehle and Bantock 2003). She
had most of the manifestations like facial and digital anomalies,
congenital heart defect, and postnatal onset growth deficiency.
She did not have gastrointestinal or renal anomalies. Pediatric
reviews until 5 years of age revealed growth failure and de-
layed neuropsychomotor milestones. Our patient also had a car-
diovascular abnormality similar to those described in 4q dele-
tions with identical breakpoints (Evers et al. 1993; Grammatico
et al. 1997).
In their literature review of 101 children with interstitial and
terminal 4q deletion syndrome, Strehle and Bantock reported
central nervous system involvement in 34% of cases. Brain
anomalies were more common in interstitial than in terminal
deletions of 4q (Strehle and Bantock 2003). Epilepsy was a fre-
quent feature (Kempen 1975; Raczenbeck et al. 1991; Suwa et
al. 1998) and several children had structural abnormalities, for
instance an absent or hypoplastic corpus callosum (Fagan and
Gill 1989; Fukushima et al. 1992), cerebral or cerebellar atro-
phy (Hoo et al. 1986; Koppitch et al. 1990; Slavotinek et al.
1997; Strehle et al. 2001) or dilated ventricles/macrocephaly
(Frappaz et al. 1983; Beall et al. 1998; Rose et al. 1991; Kul-
harya et al. 1995). The only published case of a 4q deletion as-
sociated with an encephalocele was described by Nowaczyk et
al. (1997). Their patient of Italian origin was born with a high
occipital encephalocele, which was excised at 7 days of age,
cerebellar hypoplasia, and a ventricular septal defect. Karyotype
analysis revealed an interstitial deletion of chromosome 4,
del(4)(q13.2q23). The boy died following a respiratory arrest
at the age of 7 months.
Occipital encephalocele and ocular abnormalities are char-
acteristic for patients with Knobloch syndrome. This syndrome
is caused by mutations of the gene COL18A1, which maps to
chromosome 21q22.3. COL18A1 encodes collagen XVIII,
which is a component of basement membranes. Various cell
types use basement membranes as a structure to which they
can adhere and for the transport of nutrients. It is possible that
other genes responsible for collagen production reside on chro-
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FIG. 4. G-banded partial karyotype of the patient.
FIG. 5. Chromosome 4 ideogram and plot as obtained by ar-
ray CGH. The 25.7 MB deletion is indicated by a vertical gray
bar.
mosome 4q (Marneros and Olsen 2005; Passos-Bueno et al.
2006).
Chromosomal deletion syndromes with slightly differing
breakpoints and different phenotypes contribute to the local-
ization of genes with specific functions. A review of the fea-
tures reported in patients with del(4)(q32), del(4)(q33), and
del(4)(q34) showed that there was a clear difference in the fre-
quency and severity of anomalies in children with either of these
deletions (Keeling et al. 2001). In their review of 4q deletions,
Lin and co-workers (1988) compared 2 new patients with
del(4)(q32) with 2 cases of del(4)(q32) described by Rethore et
al. (1979) and Fryns et al. (1981). All 4 patients had the
Pierre–Robin sequence, were hypotonic at birth, and developed
moderate to severe learning difficulties. Three of them had a
congenital heart defect and absent digital flexion creases, and
1 died at the age of 3 months. Other reports of patients with in-
terstitial deletions inside the terminal region 4q may contribute
to an understanding of genotype–phenotype correlations and to
an identification of the critical region and the genes responsi-
ble for the main manifestations (Sarda et al. 1992; Calabrese et
al. 1997; Robertson et al. 1998; Keeling et al. 2001; Strehle et
al. 2001; Giuffrè et al. 2004).
In less than 10% of published cases with 4q syndrome, mo-
lecular genetic techniques have been applied, for instance flu-
orescent in situ hybridization (FISH), comparative genomic hy-
bridization (CGH), representational oligonucleotide microarray
analysis (ROMA), or multiplex amplifiable probe hybridization
(MAPH) (Armour et al. 2004; Jain 2004; Jobanputra et al. 2005;
Ylstra et al. 2006). These relatively new techniques have en-
abled researchers to determine the chromosomal breakpoints in
4q deletions more accurately than previously possible with
Giemsa banding (Becker et al. 2003; Pickard et al. 2004; Van
Buggenhout et al. 2004; Eggermann et al. 2005). In addition,
they have resulted in the mapping of the genes for piebaldism
and Rieger syndrome to chromosome 4q (Spritz et al. 1992;
Flomen et al. 1997; Schinzel et al. 1997) and to the identifica-
tion of a candidate gene for autism (Ramanathan et al. 2004).
More than 200 genes were deleted in our patient as shown in
our array CGH study, including 34 genes with well-known func-
tion (a list of deleted genes can be obtained from the author).
Many of them are important for embryo development. For ex-
ample, dHAND is a basic helix–loop–helix transcription factor.
It is expressed in the developing heart and may play an impor-
tant role in cardiogenesis (Srivastava et al. 1995). Thus far,
there is no definitive correlation between dHAND deletion and
congenital heart disease (Huang et al. 2002; Vogt et al. 2006).
In mouse models, knockout of dHAND causes cardiac defects
(Firulli et al. 1998). Another gene associated with cardiovas-
cular development is VEGF-C, which is active in angiogenesis
and cell growth (Cao et al. 1998).
Previously, it was reported that chromosome 4q deletions are
associated with cervical cancer (Backsch et al. 2005), sporadic
basal cell carcinomas (Sironi et al. 2004), and hepatocarcinoma
(Bluteau et al. 2002). Several tumor suppressor genes reside in
this region. The inhibitor of growth family member-1 is able to
modify the function of histone acetylase and histone deacetyl-
ase (HDAC) and functions in DNA repair and cellular apopto-
sis (Wang et al. 2006). This raises the question whether patients
with 4q deletion syndrome should be surveyed for cancer. Cas-
pase 3 is also deleted in our patients. This protein plays a cen-
tral role in apoptosis, which is an essential process for embry-
ological development. Another gene deleted in our patient is
the FAT tumor suppressor homologue 1. This gene is highly
expressed in fetal epithelia and plays an important role in the
developmental process (Dunne et al. 1995). We would like to
point out that coagulation factor XI is also deleted in our pa-
tients. However, patients with 4q deletion syndrome have never
been reported in association with a coagulopathy.
In conclusion, the findings in our patient differ from those
previously found in patients with 46,XX,del(4)(q33) and
del(4)(q32), respectively. To our knowledge, this is the first de-
scription of a patient with a terminal 4q deletion associated with
an encephalocele. It could be more than coincidence that two
cases of 4q deletions were associated with an occipital en-
cephalocele, and therefore detailed research should be per-
formed to establish a possible link. We recommend that mo-
lecular genetic analyses be performed in all future case reports
of children with 4q deletion syndrome.
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